ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Feb 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
January 2026
Latest News
CLEAN SMART bill reintroduced in Senate
Senators Ben Ray Luján (D., N.M.) and Tim Scott (R., S.C.) have reintroduced legislation aimed at leveraging the best available science and technology at U.S. national laboratories to support the cleanup of legacy nuclear waste.
The Combining Laboratory Expertise to Accelerate Novel Solutions for Minimizing Accumulated Radioactive Toxins (CLEAN SMART) Act, introduced on February 11, would authorize up to $58 million annually to develop, demonstrate, and deploy innovative technologies, targeting reduced costs and safer, faster remediation of sites from the Manhattan Project and Cold War.
Joetta Goda, Caiser Bravo, Theresa Cutler, Travis Grove, David Hayes, Jesson Hutchinson, George McKenzie, Alexander McSpaden, William Myers, Rene Sanchez, Jessie Walker
Nuclear Science and Engineering | Volume 195 | Number 1 | November 2021 | Pages S55-S79
Technical Paper | doi.org/10.1080/00295639.2021.1947103
Articles are hosted by Taylor and Francis Online.
The work presented in this paper focuses on the first 10 years (2011–2020) of Godiva IV operations at the National Criticality Experiments Research Center (NCERC). Godiva IV is a fast burst critical assembly constructed of approximately 65 kg of highly enriched uranium fuel alloyed with 1.5% molybdenum for strength. Godiva is one of the last such critical assemblies in the United States and can be used for studies of super-prompt-critical behavior as well as irradiations and demonstrations. An overview of the startup of Godiva IV at NCERC is given followed by a summary of the experiments performed utilizing Godiva IV over the first 10 years of operation at NCERC.